About this episode
Kevin Freeman hosts Rosemary Gibson, renowned for her intense research into America's pharmaceutical vulnerabilities, particularly concerning Chinese influence over generics. With shocking revelations of the U.S. dependence on Chinese-manufactured drug components, the conversation highlights both the health risks and national security threats posed by outsourcing essential drug production. Rosemary emphasizes the need for stringent testing, accountability, and the urgent drive to return pharmaceutical manufacturing to trustworthy nations. Finally, they explore practical steps the government and individuals can take to safeguard our medicine supply chain and ensure the quality and safety of the drugs we rely on daily.
